What is the clinical evidence from this study?

Study design: Cross-Sectional. Intervention: Mission® Cholesterol 3-in-1 system vs. reference laboratory method. Primary outcome: Analytical agreement of lipid profile measurements (ICC 0.972 for triglycerides).

What does this research mean for the field?

The Mission Cholesterol 3-in-1 system demonstrates good analytical agreement and high diagnostic accuracy compared with laboratory testing, supporting its utility as a rapid point-of-care screening tool despite systematic bias. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To evaluate the analytical agreement, systematic bias, and diagnostic performance of the Mission Cholesterol 3-in-1 point-of-care system against standard laboratory reference methods.

September 28, 2026DiagnosticsOpen Access

Analytical Agreement and Diagnostic Performance of a Commercial Point-of-Care Lipid Testing System for Lipid Profile and Atherogenic Ratios

View Full Paper

Ask AI

Bookmark

Key result

Mission Cholesterol point-of-care system shows high agreement with lab lipid testing, including ~0.97 triglyceride ICC.

ICC 0.972 for triglycerides
n=120

Why the study?

Comprehensive analytical validation of point-of-care lipid testing devices against reference laboratory methods remains limited.

Does the Mission® Cholesterol 3-in-1 system provide accurate lipid profile measurements compared to reference laboratory methods in participants?

Population

120 participants

Comparison

Mission Cholesterol 3-in-1 system vs reference laboratory method

Design

Prospective cross-sectional agreement study

Authors

SGSusana Guadalupe Guzmán-Aquino RRRoberto Rivera-SánchezHospital Juárez de México KAKarla Aidee Aguayo-CerónInstituto Politécnico Nacional

Discussion

Member takes

Implication

The Mission® Cholesterol 3-in-1 point-of-care system demonstrates good analytical agreement and excellent diagnostic performance compared to reference laboratory methods, supporting its use as a rapid screening tool.

Key Points

To evaluate the analytical agreement, systematic bias, and diagnostic performance of the Mission Cholesterol 3-in-1 point-of-care system against standard laboratory reference methods.
Conducted a prospective cross-sectional agreement study among 120 participants.
Measured lipid profiles using eleven Mission Cholesterol 3-in-1 analyzers and compared them to reference laboratory testing.
Evaluated agreement and bias using intraclass correlation coefficients (ICC), concordance correlation coefficients (CCC), Bland–Altman plots, and Passing–Bablok regression.
Triglycerides demonstrated excellent agreement with laboratory references (ICC = CCC = 0.972; bias = 5.19%), while total cholesterol, HDL-C, non-HDL-C, and LDL-C showed good agreement (ICC range: 0.817–0.854).
Concordance was highest for the atherogenic ratios TG/HDL-C (ICC = 0.932) and TG/LDL-C (ICC = 0.931).
Diagnostic performance remained high across all lipid markers, yielding sensitivities of 94.29–98.33% and specificities of 68.33–91.80%, despite systematic constant and proportional biases.

Study Design

Type

Cross-Sectional (n=120)

Structured PICO

Does the Mission® Cholesterol 3-in-1 system provide accurate lipid profile measurements compared to reference laboratory methods in participants?

Population

120 participants undergoing lipid profile and atherogenic ratio measurements.

Exposure

Mission® Cholesterol 3-in-1 system (point-of-care lipid testing)

Comparator

Reference laboratory method

Outcome

Agreement, systematic bias, and diagnostic performance for lipid profile measurements and atherogenic ratiossurrogate

Main Result

Effect estimate: ICC 0.972 for triglycerides

Limitations

Systematic bias limits complete interchangeability with reference methods

Cite This Study

Guzmán-Aquino et al. (2026) reported a cross-sectional. Mission® Cholesterol 3-in-1 system vs. reference laboratory method was evaluated on Analytical agreement of lipid profile measurements (ICC 0.972 for triglycerides). The Mission® Cholesterol 3-in-1 system showed good analytical agreement with laboratory testing, including an ICC of 0.972 for triglycerides, supporting its use as a rapid point-of-care tool.

synapsesocial.com/papers/6ab9b5d07822ec8fc3d90f71 https://doi.org/10.3390/diagnostics16193116

View Full Paper

Ask AI

Bookmark

Analytical Agreement and Diagnostic Performance of a Commercial Point-of-Care Lipid Testing System for Lipid Profile and Atherogenic Ratios

Discussion

Member takes

Implication

Key Points

Study Design

Structured PICO

Main Result

Limitations

Cite This Study

Analytical Agreement and Diagnostic Performance of a Commercial Point-of-Care Lipid Testing System for Lipid Profile and Atherogenic Ratios

Discussion

Member takes

Implication

Key Points

Study Design

Structured PICO

Main Result

Limitations

Cite This Study

Also Consider

Also Consider